The development of new medicines is a long and costly process that involves significant delays and failures. The lessons learnt are rarely published making it impossible for the industry to build on them. Our team is using artificial intelligence to capture and reconstruct every drug development journey down to the specific studies conducted and results reviewed by the regulators. Using our platform, biopharmaceutical teams can benchmark their drug candidates to others and continuously assess the strengths and weaknesses of their development strategies in real time.
Our platform is relied on by mid-to-large biopharmaceutical companies (incl. top 20 pharmas) to find regulatory precedents and answer complex regulatory questions.